Restart Life Sciences Corp. (CSE:HEAL)
0.0500
+0.0050 (11.11%)
Apr 24, 2025, 4:00 PM EDT
Restart Life Sciences Statistics
Total Valuation
CSE:HEAL has a market cap or net worth of CAD 1.66 million. The enterprise value is 1.58 million.
Market Cap | 1.66M |
Enterprise Value | 1.58M |
Important Dates
The last earnings date was Tuesday, April 8, 2025.
Earnings Date | Apr 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:HEAL has 33.23 million shares outstanding. The number of shares has increased by 9.79% in one year.
Current Share Class | n/a |
Shares Outstanding | 33.23M |
Shares Change (YoY) | +9.79% |
Shares Change (QoQ) | +20.73% |
Owned by Insiders (%) | 10.13% |
Owned by Institutions (%) | 3.15% |
Float | 29.86M |
Valuation Ratios
The trailing PE ratio is 5.00.
PE Ratio | 5.00 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -5.56 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 7.01 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37
Current Ratio | 0.37 |
Quick Ratio | 0.37 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -353.47% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 209.39% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is 0.08, so CSE:HEAL's price volatility has been lower than the market average.
Beta (5Y) | 0.08 |
52-Week Price Change | -66.67% |
50-Day Moving Average | 0.08 |
200-Day Moving Average | 0.11 |
Relative Strength Index (RSI) | 40.25 |
Average Volume (20 Days) | 38,912 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -626,217 |
Pretax Income | 224,745 |
Net Income | 224,745 |
EBITDA | -623,906 |
EBIT | -626,217 |
Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 169,953 in cash and 83,931 in debt, giving a net cash position of 86,022 or 0.00 per share.
Cash & Cash Equivalents | 169,953 |
Total Debt | 83,931 |
Net Cash | 86,022 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | -299,071 |
Book Value Per Share | -0.02 |
Working Capital | -308,143 |
Cash Flow
Operating Cash Flow | -71,773 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:HEAL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.79% |
Shareholder Yield | -9.79% |
Earnings Yield | 13.53% |
FCF Yield | n/a |
Stock Splits
The last stock split was on January 24, 2025. It was a reverse split with a ratio of 0.5.
Last Split Date | Jan 24, 2025 |
Split Type | Reverse |
Split Ratio | 0.5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |